Kirby Institute
Research facility
Location:
Kensington,
Australia (AU)
Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection (2024)
Cai C, Keoshkerian E, Wing K, Samir J, Effenberger M, Schober K, Bull RA, et al.
Journal article
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability (2021)
Burnett DL, Jackson KJ, Langley DB, Aggrawal A, Stella AO, Johansen MD, Balachandran H, et al.
Journal article